Sales & Marketing
A next-generation mindset: Veeva Commercial Summit 2024
Imagine a time when all your teams collaborate seamlessly. That’s what this year’s Veeva Commercial Summit posited as it commenced.
News
Pfizer bags EU okay for haemophilia drug Hympavzi
Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU
News
FDA says no to Astellas' geographic atrophy drug
Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US.
News
Grifols linked to €7bn takeover offer from Brookfield
Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.
News
Syndax gets FDA okay for first-in-class leukaemia drug
A few days after a disappointing clinical trial readout for Syndax Pharma's Revuforj in one form of leukaemia, the company has claimed FDA approval in another.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
